Form 4: Guardant Health Director Acquires Shares via RSU Vesting

Guardant Health Director Roberto Mignone acquired 264 shares of common stock through the vesting of restricted stock units.

Summary

• Roberto Mignone, a Director at Guardant Health, Inc. (GH), reported a change in beneficial ownership.
• On November 21, 2025, Mignone acquired 264 shares of Guardant Health common stock at a price of $0 per share.
• This acquisition resulted from the conversion of 264 Restricted Stock Units (RSUs) into common stock.
• The RSU award was originally granted on November 8, 2024, with 25% vesting on October 21, 2025, and the remainder vesting monthly over the subsequent three years.
• Following this transaction, Mignone directly beneficially owns 3,431 shares of common stock and 9,240 Restricted Stock Units.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine insider transaction (RSU vesting) which is expected. The director's continued ownership of shares and RSUs aligns their interests with shareholders, which is generally viewed favorably.

Positives

• A director increasing their direct ownership of common stock, even through RSU vesting, can be seen as a positive signal of continued alignment with shareholder interests.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the vesting schedule of the reported Restricted Stock Units.

Industry Context

This is a routine insider transaction filing, common for directors and executives receiving equity compensation. It does not provide broader industry context or competitive analysis.

Stakeholder Impact

• Shareholders: The transaction indicates a director's continued equity stake, aligning their interests with long-term shareholder value.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The remaining 9,240 Restricted Stock Units held by Roberto Mignone are expected to vest monthly over the next three years, following the initial 25% vesting.

Key Dates

Recommendation

This Form 4 filing reports a routine, non-discretionary acquisition of shares by a director through RSU vesting. While it shows continued alignment of interests, it does not present new information that would fundamentally alter the investment thesis for Guardant Health, hence a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Guardant Health, GH, Form 4, Insider Transaction, Director Stock Acquisition, Restricted Stock Units, RSU Vesting, Beneficial Ownership